Pilot Study of Mirabegron in Pediatric Patients With Overactive Bladder
Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The objective is to evaluate the efficacy and safety of mirabegron to treat urinary
incontinence in children with Overactive Bladder that are refractory and/or intolerant to
antimuscarinics.
Phase:
Phase 3
Details
Lead Sponsor:
Centre Hospitalier Universitaire de Québec, CHU de Québec CHU de Quebec-Universite Laval